Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2025 Filed May 28, 2025 20:11 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015807 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,086 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:10 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015806 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,391 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:08 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015804 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,965 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:09 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015805 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,914 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:07 UTC |
Ling KarenDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015803 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,676 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:06 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015802 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,699 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:04 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015801 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,147 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:03 UTC |
Hu GaoxiangDirector
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015800 · form4.xml · nonDerivative · entry 1 Hu Gaoxiang · CIK 0001839091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,147 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:01 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015799 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,663 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 22, 2025 Filed May 27, 2025 12:16 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantCommon Shares, No Par Value | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015582 · form4.xml · nonDerivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 741,156 F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| May 22, 2025 Filed May 27, 2025 12:16 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
PurchaseCommon Shares, No Par Value | 22,000 | $11.28 | $248,072.00 |
DisclosureSEC source: 0001127602-25-015582 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719,156 F1 · shares: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.19 to $11.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:30 UTC |
VON ESCHENBACH ANDREW C.Director
|
PurchaseCommon Shares, No Par Value | 1,695 | $11.76 | $19,924.73 |
DisclosureSEC source: 0001127602-25-013477 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,748 Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:02 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 2,210 | $11.59 | $25,613.90 |
DisclosureSEC source: 0001127602-25-013332 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,576 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:00 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,887 | $11.59 | $21,870.33 |
DisclosureSEC source: 0001127602-25-013331 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,627 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 20:06 UTC |
Stewart Andrew J.See remarks
|
Tax withholdingCommon Shares, No Par Value | 3,954 | $13.89 | $54,921.06 |
DisclosureSEC source: 0001127602-25-012622 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,930 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 20:05 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
Tax withholdingCommon Shares, No Par Value | 9,781 | $13.89 | $135,858.09 |
DisclosureSEC source: 0001127602-25-012621 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,576 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:22 UTC |
Bonnefoy LucPresident,Surgical
|
Tax withholdingCommon Shares, No Par Value | 3,029 | $16.00 | $48,464.00 |
DisclosureSEC source: 0001127602-25-007508 · form4.xml · nonDerivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,351 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:22 UTC |
Bonnefoy LucPresident,Surgical
|
Tax withholdingCommon Shares, No Par Value | 1,110 | $16.00 | $17,760.00 |
DisclosureSEC source: 0001127602-25-007508 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,380 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:28 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 60,085 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007272 · form4.xml · derivative · entry 2 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,085 Underlying: Common Shares, No Par Value · 60,085 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:28 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantCommon Shares, No Par Value | 25,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007272 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,580 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:31 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 18,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007279 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,294 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:30 UTC |
Bonnefoy LucPresident,Surgical
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 55,793 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007278 · form4.xml · derivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,793 Underlying: Common Shares, No Par Value · 55,793 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:30 UTC |
Bonnefoy LucPresident,Surgical
|
GrantCommon Shares, No Par Value | 23,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007278 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,490 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:29 UTC |
Stewart Andrew J.See remarks
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 55,793 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007275 · form4.xml · derivative · entry 2 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,793 Underlying: Common Shares, No Par Value · 55,793 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:29 UTC |
Stewart Andrew J.See remarks
|
GrantCommon Shares, No Par Value | 23,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007275 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,884 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:27 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 96,566 | $15.86 Strike: $15.86 | $1,531,536.76 |
DisclosureSEC source: 0001127602-25-007270 · form4.xml · derivative · entry 2 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,566 Underlying: Common Shares, No Par Value · 96,566 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:27 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantCommon Shares, No Par Value | 40,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007270 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,357 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:25 UTC |
Eldessouky SamEVP and CFO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 141,630 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007267 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,630 Underlying: Common Shares, No Par Value · 141,630 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:25 UTC |
Eldessouky SamEVP and CFO
|
GrantCommon Shares, No Par Value | 59,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007267 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,295 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:23 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 600,858 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007260 · form4.xml · derivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,858 Underlying: Common Shares, No Par Value · 600,858 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:23 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantCommon Shares, No Par Value | 168,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007260 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,156 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:14 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,751 | $17.83 | $49,050.33 |
DisclosureSEC source: 0001127602-24-030053 · form4.xml · nonDerivative · entry 2 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,355 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:14 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,324 | $17.83 | $41,436.92 |
DisclosureSEC source: 0001127602-24-030053 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,106 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:16 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 2,192 | $17.83 | $39,083.36 |
DisclosureSEC source: 0001127602-24-030054 · form4.xml · nonDerivative · entry 2 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,713 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:16 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 908 | $17.83 | $16,189.64 |
DisclosureSEC source: 0001127602-24-030054 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,905 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:19 UTC |
Stewart Andrew J.See remarks
|
Tax withholdingCommon Shares, No Par Value | 2,524 | $17.83 | $45,002.92 |
DisclosureSEC source: 0001127602-24-030058 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,461 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:18 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 24,649 | $17.83 | $439,491.67 |
DisclosureSEC source: 0001127602-24-030056 · form4.xml · nonDerivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,988 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:18 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 73,782 | $17.83 | $1,315,533.06 |
DisclosureSEC source: 0001127602-24-030056 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 553,637 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:13 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 8,582 | $17.83 | $153,017.06 |
DisclosureSEC source: 0001127602-24-030052 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,836 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:13 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 7,249 | $17.83 | $129,249.67 |
DisclosureSEC source: 0001127602-24-030052 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,418 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:12 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
Tax withholdingCommon Shares, No Par Value | 4,402 | $17.83 | $78,487.66 |
DisclosureSEC source: 0001127602-24-030050 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,817 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 23:14 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,328 | $19.29 | $25,617.12 |
DisclosureSEC source: 0001127602-24-024770 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,694 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 23:12 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,134 | $19.29 | $21,874.86 |
DisclosureSEC source: 0001127602-24-024769 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,874 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 21:29 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantCommon Shares, No Par Value | 32,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021823 · form4.xml · nonDerivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,419 F2 · shares: Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares reported on Table I above, pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the Reporting Person's continued service (except in limited circumstances). Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 21:29 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
PurchaseCommon Shares, No Par Value | 32,250 | $15.66 | $505,067.25 |
DisclosureSEC source: 0001127602-24-021823 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,169 F1 · shares: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.395 to $15.8 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:07 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021761 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,053 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:06 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021760 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,053 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:05 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021759 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,366 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:04 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021758 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,740 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:56 UTC |
Ling KarenDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021757 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,338 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.